Kerala Ayurveda Limited (BOM:530163)
171.10
+10.50 (6.54%)
At close: Aug 17, 2026
Kerala Ayurveda Revenue
Kerala Ayurveda had revenue of 334.54M INR in the quarter ending June 30, 2026, with 16.92% growth. This brings the company's revenue in the last twelve months to 1.27B, up 2.62% year-over-year. In the fiscal year ending March 31, 2026, Kerala Ayurveda had annual revenue of 1.31B with 8.99% growth.
Revenue (ttm)
1.27B
Revenue Growth
+2.62%
P/S Ratio
1.72
Revenue / Employee
3.45M
Employees
367
Market Cap
2.17B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.31B | 108.12M | 8.99% |
| Mar 31, 2025 | 1.20B | 171.82M | 16.66% |
| Mar 31, 2024 | 1.03B | 95.28M | 10.18% |
| Mar 31, 2023 | 936.23M | 131.79M | 16.38% |
| Mar 31, 2022 | 804.44M | 183.70M | 29.59% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.34B |
| Parnax Lab | 2.52B |
| Sat Kartar Life | 2.01B |
| Everest Organics | 1.92B |
| Gennex Laboratories | 1.78B |
| Oxygenta Pharmaceutical | 1.35B |
| Coral Laboratories | 968.04M |
| Accretion Pharmaceuticals | 896.27M |